Evidence map›Paper›PMID 42781676›Full record

ArticleCureus2026

Snapchat Usage Intensity and Symptoms of Depression and Anxiety Among Adults in a Central Region of Saudi Arabia: A Cross-Sectional Study.

Fuhaid Alqossayir

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fuhaid AlqossayirDepartment of Family and Community Medicine, College of Medicine, Qassim University, Qassim, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSocial media platforms, including Snapchat, are widely used across age groups in Saudi Arabia. Evidence on how intensity of use relates to symptoms of depression and anxiety among adults in the region remains limited. This study examined the association between Snapchat usage intensity and symptoms of depression and anxiety among adults in the Qassim region of Saudi Arabia. METHODOLOGY: A cross-sectional Arabic-language online survey was conducted between January and August 2023 in Buraydah City. Adults aged 18 to 65 years who used Snapchat at least two to four times daily were recruited from 12 schools through randomized cluster selection combined with voluntary participation among school staff and their adult family members. Snapchat usage intensity was measured using a six-item scale adapted from the Facebook Intensity Scale (range, 6-30), and symptoms of depression and anxiety were assessed using the Arabic versions of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7). Spearman's rank-order correlation and multivariable linear regression adjusted for age, marital status, and income were performed, with significance set at

resultsA total of 323 adults participated (mean age, 32.6 ± 9.5 years; 203 (62.8%) female). The mean Snapchat intensity score was 17.78 (standard deviation (SD), 5.56), with no significant gender difference (mean difference, 0.41; 95% confidence interval (CI), -0.85 to 1.67;

conclusionsSnapchat usage intensity showed a small positive association with symptoms of depression and anxiety. The effect sizes were small, accounting for less than 10% of the variance in symptom scores, and the cross-sectional design precludes any inference about direction. In a sensitivity analysis, the association was attenuated by adjustment for problematic social media use.

Indexed as

anxietydepressioneffects of social mediaepidemiologypreventive medicinesnapchat intensity score

Identifiers

PMID42781676
PMCPMC13600568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.